Brind.

Vanda Pharmaceuticals participated in investor conferences held in New York City and Boston, while Wells Fargo hosted a conference in Boston.

3 reports, 2 independent Updated Sep 2

Gone quiet

Reports: 3
Developments: 1
Repetition: 67%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Vanda Pharmaceuticals participated in investor conferences held in New York City and Boston, while Wells Fargo hosted a conference in Boston.

Who's involved

What this event is mainly about

Vanda Pharmaceuticals (United States)Wells Fargo

Keep exploring

The entities involved

Vanda Pharmaceuticals (United States)
company in Washington D.C., United States

Nothing else this week.
Wells Fargo
American multinational banking and financial services company
- Wells Fargo upgraded Sweetgreen stock to overweight from equal weight on September 28, 2026.Mon 16:33
- Capital Research Global Investors acquired and increased its stake in Wells Fargo stock on June 19, 2026.Mon 16:28

Coverage

Newest first; wire copies grouped

Jul 10prnewswire.com
Aug 29PR NewswireVanda Pharmaceuticals Announces Participation at September 2025 Investor Conferences WASHINGTON, Aug. 28, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that t

1 more outlet ran the same wire story

Sep 2prnewswire.com